ɬÀï·¬

Sabrina Wurzba (PhD)

Academic title(s): 
  • Associate Professor, Faculty of Medicine, ɬÀï·¬
  • Principal Investigator, Lady Davis Institute, Segal Cancer Center
  • Research Director, Jewish General Hospital
Contact Information
Email address: 
sabrina.wurzba [at] mcgill.ca
Degree(s): 

DDS, MSc, PhD

Location: 
Jewish General Hospital
Division: 
Research Program
Current research: 

Translation and Innovation
Precision Health
Surgical Outcomes and Quality
Regenerative Medicine
Surgical Oncology
Data Science

Clinical Interests: 

Invasive tumors; HPV associated malignancies

Language(s) spoken: 
French
English
Biography: 

Dr Wurzba DDS, MSc, PhD is an associate professor at the Department of Otolaryngology – Head and Neck Surgery at ɬÀï·¬ and a principal investigator at the Lady Davis Institute for Medical Research - Segal Cancer Center. She obtained her DDS from the University of Sao Paulo State, Brazil and her MSc and PhD in Pathology and Molecular Biology from the University of Campinas (UNICAMP, Brazil). Following her doctoral studies, Dr. Wurzba completed a postdoctoral training in Genetic/Genomics in Oncology at the Ludwig Cancer Institute under the mentorship of Dr Luiz Paulo Kowalski, a leading expert at AC Camargo Cancer Center. She gained extensive experience in oncology, which she expanded upon trough a complementary postdoctoral training in Experimental Medicine at ɬÀï·¬, focusing on tumor progression mechanisms and developing orthotopic metastatic models using patient-derived tissues.

Currently, Dr. Wurzba leads innovative basic and translational research aimed to improve prevention, early tumor detection, and discover alternative therapeutic approaches for patients with advanced cancer. Dr. Wurzba's work centers on the intricate relationship between infections, particularly human papillomavirus (HPV), and the tumor microenvironment. She investigates the key molecular pathways that drive tumor progression and therapeutic resistance, using cutting-edge molecular techniques and diagnostic tools to tackle critical challenges in oncology. Her ultimate aim is to enhance early detection methods, refine staging criteria, and develop personalized, targeted interventions for aggressive cancers, paving the way for improved patient outcomes.

Dr Wurzba’s research has been published in several peer-reviewed biomedical and medical international journals and she has contributed to book chapters related to the field of oncology science. She has been presented at national and international conferences, including the American Association Head and Neck Society, the Canadian Society of Otolaryngology, the International Academy of Oral Oncology, and International Papillomavirus Society. She also has been serving on several national and international grant panels, editorial boards of biomedical/medical journals, selection and evaluation committees

Selected publications: 

Back to top